04/02/2019

Important Oncology Related News

Doctors’ Group Cannot Sue Over Cuts To Medicare Drug Reimbursements
Apr 1, 2019 - A federal judge in Washington, D.C. has ruled that an association of oncologists cannot pursue a lawsuit challenging a 2 percent cut in reimbursements by Medicare for medications administered by healthcare providers including cancer drugs.  READ ARTICLE

BREAKING: HRSA unveils new website to gauge 340B drug prices

The Health Resources & Services Administration (HRSA) has launched a new secure website intended to serve as a tool through which safety-net healthcare providers participating in the 340B federal drug pricing program can determine the maximum prices pharmaceutical companies can charge them for medications sold to them under the program, Administration officials announced this week.

Read the full story →

Access to Care and Drug Pricing: An Update for 2019

(ASH) Mar 22, 2019 - Two big healthcare issues stand out as priorities for the 116th Congress; access to care and the cost of prescription drugs. READ ARTICLE

FDA’s Oncology Center of Excellence Touts 2018 Accomplishments

(Regulatory Focus) Mar 26, 2019 - The US Food and Drug Administration’s (FDA) recently created inter-center Oncology Center of Excellence (OCE) on Monday released its first-ever annual report touting its accomplishments in 2018. READ ARTICLE 

Urge Congress to Support Cancer Treatment Fairness

(ASCO in Action) Mar 15, 2019 - Members of Congress recently introduced oral parity legislation to ensure patients have access to the highest-quality cancer treatment. READ ARTICLE